Your browser doesn't support javascript.
loading
Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma.
Lin, Benjamin; Ziebro, Julia; Smithberger, Erin; Skinner, Kasey R; Zhao, Eva; Cloughesy, Timothy F; Binder, Zev A; O'Rourke, Donald M; Nathanson, David A; Furnari, Frank B; Miller, C Ryan.
Afiliación
  • Lin B; Department of Pathology, Division of Neuropathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Ziebro J; Department of Pathology, Division of Neuropathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Smithberger E; Department of Pathology, Division of Neuropathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Skinner KR; Pathobiology and Translational Sciences Program, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Zhao E; Department of Pathology, Division of Neuropathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Cloughesy TF; Neurosciences Curriculum, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Binder ZA; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • O'Rourke DM; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Nathanson DA; Department of Neurosurgery and Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Furnari FB; Department of Neurosurgery and Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Miller CR; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Neuro Oncol ; 25(1): 213, 2023 Jan 05.
Article en En | MEDLINE | ID: mdl-36416495

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos